Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.678 USD | +0.74% | -9.96% | -38.92% |
31/05 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
15/04 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.92% | 9.74M | |
+22.10% | 46.55B | |
+47.02% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Transcript : Organovo Holdings, Inc., Q1 2017 Earnings Call, Aug 04, 2016